Back to results
US 10,947,592 B2Granted
Method for detecting cystic fibrosis
AssigneeQuest Diagnostics Investments Incorporated
InventorSteven Patrick Rivera
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods for simultaneously determining the presence or absence of mutations, deletions, duplications and single nucleotide polymorphisms in a cystic fibrosis transmembrane regulator (CFTR) nucleic acid. Oligonucleotide primers and kits used to amplify regions of a CFTR nucleic acid for high throughput, massively parallel sequencing and methods of determining an individual's cystic fibrosis status are also disclosed.
Claims4
A kit comprising an oligonucleotide primer selected from the group consisting of SEQ ID NOs:
- 3-8, 55-60, 107, 108, 141, and 142, wherein the primer further comprises a fluorescent label.
Dependencies are inferred from the claim text.